Conditions: Uterine Fibroids
Keywords: Uterine Fibroids
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 27
Healthy volunteers: yes

Brief summary:
Safety and efficacy study of 25 and 50 mg doses of Proellex

Detailed description:
The study is intended to provide more abundant safety and efficacy data of both the 25 and 50 mg doses of Proellex than ZPU-301, ZPU-302, ZPU-303 and ZPU-304 alone.

Arms:
arm 1: 2, 25 mg capsules arm 2: 1, 25 mg capsule

Interventions: intervention 1: Proellex intervention 2: Proellex
Intervention descriptions: intervention 1: 2, 25 mg capsules once per day intervention 2: 1, 25 mg capsule once per day

Protocol document: